Glycerol-3-phosphate is an FGF23 regulator derived from the injured kidney

Petra Šimić(Massachusetts General Hospital), Eugene P. Rhee(Mass General Brigham), Jerold Chun(Sanford Burnham Prebys Medical Discovery Institute), Wen Zhou(Massachusetts Institute of Technology), Andrew M. Tager(Harvard University), David E. Leaf(Brigham and Women's Hospital), Marc N. Wein(Broad Institute), Nicolas Govea(Massachusetts General Hospital), Bryan Kestenbaum(University of Washington), Ian H. de Boer(The Ohio State University), Ravi Thadhani(Emory Healthcare), Najihah Aziz(Center for Cancer Research), Sammy Elmariah(Brigham and Women's Hospital), Robert E. Gerszten(Beth Israel Deaconess Medical Center), Clary B. Clish(Broad Institute), Harald Jüppner(Harvard University), Sushrut S. Waikar(Metabolism and Renal Physiology), Paola Divieti Pajevic(Boston University), David B. Sykes(Harvard University), Marta Christov(Harvard University), Wondong Kim(Massachusetts General Hospital), Kerry A. Pierce(Broad Institute), Wenhan Chang(San Francisco VA Medical Center), Zhiqiang Cheng(Kaifeng University), Debby Ngo(Beth Israel Deaconess Medical Center)
Journal of Clinical Investigation
February 16, 2020
Cited by 124


Related Papers